This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Pierre Fabre Dermo-Cosmetique, Université Pierre Et Marie Curie (Paris 6). Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
2 out of 84 
2 out of 158 
Years Active: 2015-2017
Title: Philippe Lebaron: Innovator in Dermatological Solutions
Introduction
Philippe Lebaron is a notable inventor based in Banyuls-sur-Mer, France. He has made significant contributions to the field of dermatology through his innovative research and inventions. With a total of 2 patents, his work focuses on the application of novel bacterial strains in treating inflammatory disorders.
Latest Patents
Lebaron's latest patents include a groundbreaking invention related to a novel bacterial strain isolated from groundwater. This invention encompasses bacterial extracts and their use in treating inflammations, particularly in dermatological pathologies. The compositions developed from this research aim to prevent and treat inflammatory disorders effectively.
Career Highlights
Throughout his career, Philippe Lebaron has worked with esteemed organizations such as Pierre Fabre Dermo-Cosmetique and Université Pierre et Marie Curie (Paris 6). His experience in these institutions has allowed him to advance his research and contribute to the development of innovative dermatological solutions.
Collaborations
Lebaron has collaborated with notable colleagues, including Muriel Bourrain and Nathalie Castex-Rizzi. These partnerships have enriched his research endeavors and fostered a collaborative environment for innovation.
Conclusion
Philippe Lebaron's contributions to dermatology through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments in the field of inflammatory disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile